Skip to main content


Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine


Finally, we have addressed some relevant findings on the importance of having well-defined synthetic strategies developed for the generation of MNPs, with a focus on particle formation mechanism and recent modifications made on the preparation of monodisperse samples of relatively large quantities not only with similar physical features, but also with similar crystallochemical characteristics. Then, different methodologies for the functionalization of the prepared MNPs together with the characterization techniques are explained. Theorical views on the magnetism of nanoparticles are considered.


Nanoscience is one of the most important research in modern science. Nanotechnology is beginning to allow scientists, engineers, chemists, and physicians to work at the molecular and cellular levels to produce important advances in the life sciences and healthcare. The use of nanoparticle [NP] materials offers major advantages due to their unique size and physicochemical properties. Because of the widespread applications of magnetic nanoparticles [MNPs] in biotechnology, biomedical, material science, engineering, and environmental areas, much attention has been paid to the synthesis of different kinds of MNPs [13].

Real uses of nanostructured materials in life sciences are uncommon at the present time. However, the excellent properties of these materials provide a very promising future for their use in this field [47]. Nanoclusters are ultrafine particles of nanometer dimensions located between molecules and microscopic structures (micron size). Viewed as materials, they are so small that they exhibit characteristics that are not observed in larger structures (even 100 nm); viewed as molecules, they are so large that they provide access to realms of quantum behavior that are not otherwise accessible. In this size, many recent advances have been made in biology, chemistry, and physics [811]. The preparation of monodisperse-sized nanocrystals is very important because the properties of these nanocrystals depend strongly on their dimensions [12, 13]. The preparation of monodisperse-sized nanocrystals with controllable sizes is very important to characterize the size-dependent physicochemical properties of nanocrystals [1416].

Industrial applications of magnetic nanoparticles cover a broad spectrum of magnetic recording media and biomedical applications, for example, magnetic resonance contrast media and therapeutic agents in cancer treatment [17, 18]. Each potential application of the magnetic nanoparticles requires having different properties. For example, in data storage applications, the particles need to have a stable, switchable magnetic state to represent bits of information that are not affected by temperature fluctuations.

For biomedical uses, the application of particles that present superparamagnetic behavior at room temperature is preferred [1921]. Furthermore, applications in therapy and biology and medical diagnosis require the magnetic particles to be stable in water at pH 7 and in a physiological environment. The colloidal stability of this fluid will depend on the charge and surface chemistry, which give rise to both steric and coulombic repulsions and also depend on the dimensions of the particles, which should be sufficiently small so that precipitation due to gravitation forces can be avoided [22]. Additional restrictions to the possible particles could be used for biomedical applications (in vivo or in vitro applications). For in vivo applications, the magnetic nanoparticles must be encapsulated with a biocompatible polymer during or after the preparation process to prevent changes from the original structure, the formation of large aggregates, and biodegradation when exposed to the biological system. The nanoparticle coated with polymer will also allow binding of drugs by entrapment on the particles, adsorption, or covalent attachment [2325]. The major factors, which determine toxicity and the biocompatibility of these materials, are the nature of the magnetically responsive components, such as magnetite, iron, nickel, and cobalt, and the final size of the particles, their core, and the coatings. Iron oxide nanoparticles such as magnetite (Fe3O4) or its oxidized form maghemite (γ-Fe2O3) are by far the most commonly employed nanoparticles for biomedical applications. Highly magnetic materials such as cobalt and nickel are susceptible to oxidation and are toxic; hence, they are of little interest [2628]. Moreover, the major advantage of using particles of sizes smaller than 100 nm is their higher effective surface areas, lower sedimentation rates, and improved tissular diffusion [2931]. Another advantage of using nanoparticles is that the magnetic dipole-dipole interactions are significantly reduced because they scale as r6 [32]. Therefore, for in vivo biomedical applications, magnetic nanoparticles must be made of a non-toxic and non-immunogenic material, with particle sizes small enough to remain in the circulation after injection and to pass through the capillary systems of organs and tissues, avoiding vessel embolism. They must also have a high magnetization so that their movement in the blood can be controlled with a magnetic field and so that they can be immobilized close to the targeted pathologic tissue [3335]. For in vitro applications, composites consisting of superparamagnetic nanocrystals dispersed in submicron diamagnetic particles with long sedimentation times in the absence of a magnetic field can be used because the size restrictions are not so severe as in in vivo applications. The major advantage of using diamagnetic matrixes is that the superparamagnetic composites can be easily prepared with functionality.

In almost all uses, the synthesis method of the nanomaterials represents one of the most important challenges that will determine the shape, the size distribution, the particle size, the surface chemistry of the particles, and consequently their magnetic properties [3638]. Ferri- and ferromagnetic materials such as Fe3O4 and some alloys have irregular particle shape when obtained by grinding bulk materials but can have a spherical shape when synthesized by plasma atomization, wet chemistry, or from the gas phases and aerosol. Also, depending on the mechanism of formation, spherical particles obtained in a solution can be crystalline or amorphous if they result from a disordered or ordered aggregation of crystallites, respectively. In addition, the synthesis method determines to a great extent the degree of structural defects or impurities in the particle as well as the distribution of such defects within the particle, therefore, determining its magnetic behavior [39, 40]

Recently, many attempts have been made to develop techniques and processes that would yield 'monodispersed colloids' consisting of uniform nanoparticles both in size and shape [4143]. In these systems, the entire uniform physicochemical properties directly reflect the properties of each constituent particle. Monodispersed colloids have been exploited in fundamental research and as models in the quantitative assessment of properties that depend on the particle size and shape. In addition, it has become evident that the reproducibility and quality of commercial products can be more readily achieved by starting with well-defined powders of known properties. In this way, these powders have found uses in photography, inks in printing, catalysis, ceramic, and especially in medicine.

Magnetic nanoparticles show remarkable new phenomena such as high field irreversibility, high saturation field, superparamagnetism, extra anisotropy contributions, or shifted loops after field cooling. These phenomena arise from narrow and finite-size effects and surface effects that dominate the magnetic behavior of individual nanoparticles [44]. Frenkel and Dorfman [45] were the first to predict that a particle of ferromagnetic material, below a critical particle size (< 15 nm for the common materials), would consist of a single magnetic domain, i.e., a particle that is in a state of uniform magnetization at any field. The magnetization behavior of these particles above a certain temperature, i.e., the blocking temperature, is identical to that of atomic paramagnets (superparamagnetism) except that large susceptibilities and, thus, an extremely large moment are involved [46].

The first part of this review is concerned with the physical properties of magnetic nanoparticles and their magnetometric property. The second part deals with the possible use of magnetic nanoparticles for biomedical application with special emphasis on the advantage of using nanoparticles with respect to microparticles and on some of the recent environmental, industrial, biological, and analytical applications of MNPs. The third part deals with the different methods described in the bibliography that are capable of producing these magnetic nanoparticles with a very narrow particle size distribution, mainly based on magnetite or maghemite iron oxide nanoparticles [47, 48]. Finally, we address some of the most relevant preparation effects on the magnetic properties and structure of the magnetic nanoparticles.

Preparation Methods

During the last few years, a large portion of the published articles about MNPs have described efficient routes to attain shape-controlled, highly stable, and narrow size distribution MNPs. Up to date, several popular methods including co-precipitation, microemulsion, thermal decomposition, solvothermal, sonochemical, microwave assisted, chemical vapour deposition, combustion synthesis, carbon arc, laser pyrolysis synthesis have been reported for synthesis of MNPs.

Physical properties of magnetic nanoparticles

Magnetic effects are caused by movements of particles that have both mass and electric charges. These particles are electrons, holes, protons, and positive and negative ions. A spinning electric-charged particle creates a magnetic dipole, so-called magneton. In ferromagnetic materials, magnetons are associated in groups. A magnetic domain (also called a Weiss domain) refers to a volume of ferromagnetic material in which all magnetons are aligned in the same direction by the exchange forces. This concept of domains distinguishes ferromagnetism from paramagnetism. The domain structure of a ferromagnetic material determines the size dependence of its magnetic behavior. When the size of a ferromagnetic material is reduced below a critical value, it becomes a single domain. Fine particle magnetism comes from size effects, which are based on the magnetic domain structure of ferromagnetic materials. It assumes that the state of lowest free energy of ferromagnetic particles has uniform magnetization for particles smaller than a certain critical size and has nonuniform magnetization for larger particles. The former ones are referred to as single domain particles, while the latter are called multidomain particles [49, 50]. According to the magnetic domain theory, the critical size of the single domain is affected by several factors including the value of the magnetic saturation, the strength of the crystal anisotropy and exchange forces, surface or domain-wall energy, and the shape of the particles. The reaction of ferromagnetic materials on an applied field is well described by a hysteresis loop, which is characterized by two main parameters: remanence and coercivity. The latter is related to the 'thickness' of the curve. Dealing with fine particles, the coercivity is the single property of most interest, and it is strongly size-dependent. It has been found that as the particle size is reduced, the coercivity increases to a maximum and then decreases toward zero (Figure 1).

Figure 1

Schematic illustration of the coercivity-size relations of small particles.

When the size of single-domain particles further decreases below a critical diameter, the coercivity becomes zero, and such particles become superparamagnetic. Superparamagnetism is caused by thermal effects. In superparamagnetic particles, thermal fluctuations are strong enough to spontaneously demagnetize a previously saturated assembly; therefore, these particles have zero coercivity and have no hysteresis. Nanoparticles become magnetic in the presence of an external magnet, but revert to a nonmagnetic state when the external magnet is removed. This avoids an 'active' behavior of the particles when there is no applied field. Introduced in the living systems, particles are 'magnetic' only in the presence of an external field, which gives them unique advantage in working in biological environments. There are a number of crystalline materials that exhibit ferromagnetism, among others Fe, Co, or Ni. Since ferrite oxide-magnetite (Fe3O4) is the most magnetic of all the naturally occurring minerals on earth, it is widely used in the form of superparamagnetic nanoparticles for all sorts of biological applications [5153].

Magnetic property (magnetic behavior)

Materials are classified by their response to an externally applied magnetic field. Descriptions of orientations of the magnetic moments in a material help identify different forms of magnetism observed in nature. Five basic types of magnetism can be described: diamagnetism, paramagnetism, ferromagnetism, antiferromagnetism, and ferrimagnetisms. In the presence of an externally applied magnetic field, the atomic current loops created by the orbital motion of electrons respond to oppose the applied field. All materials display this type of weak repulsion to a magnetic field known as diamagnetism. However, diamagnetism is very weak, and therefore, any other form of magnetic behavior that a material may possess usually overpowers the effects of the current loops. In terms of the electronic configuration of the materials, diamagnetism is observed in materials with filled electronic subshells where the magnetic moments are paired and overall cancel each other. Diamagnetic materials have a negative susceptibility (χ < 0) and weakly repel an applied magnetic field (e.g., quartz SiO2). The effects of these atomic current loops are overcome if the material displays a net magnetic moment or has a long-range ordering of its magnetic moments [5456]. All other types of magnetic behaviors are observed in materials that are at least partially attributed to unpaired electrons in their atomic shells, often in the 3d or 4f shells of each atom. Materials whose atomic magnetic moments are uncoupled display paramagnetism; thus, paramagnetic materials have moments with no long-range order, and there is a small positive magnetic susceptibility (χ ≈ 0), e.g., pyrite [5759]. Materials that possess ferromagnetism have aligned atomic magnetic moments of equal magnitude, and their crystalline structures allow for direct coupling interactions between the moments, which may strongly enhance the flux density (e.g., Fe, Ni, and Co). Furthermore, the aligned moments in ferromagnetic materials can confer a spontaneous magnetization in the absence of an applied magnetic field. Materials that retain permanent magnetization in the absence of an applied field are known as hard magnets. Materials having atomic magnetic moments of equal magnitude that are arranged in an antiparallel fashion display antiferromagnetism (e.g., troilite FeS). The exchange interaction couples the moments in such a way that they are antiparallel, therefore, leaving a zero net magnetization [60]. Above the Néel temperature, thermal energy is sufficient to cause the equal and oppositely aligned atomic moments to randomly fluctuate, leading to a disappearance of their long-range order. In this state, the materials exhibit paramagnetic behavior. Ferrimagnetism is a property exhibited by materials whose atoms or ions tend to assume an ordered but nonparallel arrangement in a zero applied field below a certain characteristic temperature known as the Néel temperature (e.g., Fe3O4 and Fe3S4). In the usual case, within a magnetic domain, a substantial net magnetization results from the antiparallel alignment of neighboring non-equivalent sublattices. The macroscopic behavior is similar to ferromagnetism. Above the Néel temperature, the substance becomes paramagnetic (Figure 2) [61, 62].

Figure 2

Magnetization behavior of ferromagnetic and superparamagnetic NPs under an external magnetic field. (a) Under an external magnetic field, domains of a ferromagnetic NP align with the applied field. The magnetic moment of single domain superparamagnetic NPs aligns with the applied field. In the absence of an external field, ferromagnetic NPs will maintain a net magnetization, whereas superparamagnetic NPs will exhibit no net magnetization due to rapid reversal of the magnetic moment. (b) Relationship between NP size and the magnetic domain structures. Ds and Dc are the 'superparamagnetism' and 'critical' size thresholds.


Industrial applications

Magnetic iron oxides are commonly used as synthetic pigments in ceramics, paints, and porcelain. Magnetic encapsulates may find very important uses in many areas of life and also in various branches of industry. Such materials are interesting from both points of the fundamental study of materials science as well as their applications [63, 64]. Hematite and magnetite have been applied as catalysts for a number of important reactions, such as the preparation of NH3, the desulfurization of natural gas, and the high-temperature water-gas shift reaction. Other reactions include the Fishere-Tropsch synthesis for hydrocarbons, the dehydrogenation of ethylbenzene to styrene, the oxidation of alcohols, and the large-scale synthesis of butadiene [6567].

Biomedical applications

Biomedical applications of magnetic nanoparticles can be classified according to their application inside or outside the body (in vivo, in vitro). For in vitro applications, the main use is in diagnostic separation, selection, and magnetorelaxometry, while for in vivo applications, it could be further separated in therapeutic (hyperthermia and drug-targeting) and diagnostic applications (nuclear magnetic resonance [NMR] imaging) [6870].

In vivo applications

Two major factors play an important role for the in vivo uses of these particles: size and surface functionality. Even without targeting surface ligands, superparamagnetic iron oxide NP [SPIOs] diameters greatly affect in vivo biodistribution. Particles with diameters of 10 to 40 nm including ultra-small SPIOs are important for prolonged blood circulation; they can cross capillary walls and are often phagocytosed by macrophages which traffic to the lymph nodes and bone marrow [71].

1. Therapeutic applications. Hyperthermia: Placing superparamagnetic iron oxide in altering current [AC] magnetic fields randomly flips the magnetization direction between the parallel and antiparallel orientations, allowing the transfer of magnetic energy to the particles in the form of heat, a property that can be used in vivo to increase the temperature of tumor tissues to destroy the pathological cells by hyperthermia. Tumor cells are more sensitive to a temperature increase than healthy ones [72, 73]. In past studies, magnetite cationic liposomal nanoparticles and dextran-coated magnetite [74] have been shown to effectively increase the temperature of tumor cells for hyperthermia treatment in cell irradiation. This has been proposed to be one of the key approaches to successful cancer therapy in the future [75]. The advantage of magnetic hyperthermia is that it allows the heating to be restricted to the tumor area. Moreover, the use of subdomain magnetic particles (nanometer-sized) is preferred instead multidomain (micron-sized) particles because nanoparticles absorb much more power at tolerable AC magnetic fields [76, 77] which is strongly dependent on the particle size and shape, and thus, having well-defined synthetic routes able to produce uniform particles is essential for a rigorous control in temperature.

2. Drug delivery. Drug targeting has emerged as one of the modern technologies for drug delivery. The possibilities for the application of iron oxide magnetic nanoparticles in drug targeting have drastically increased in recent years [78]. MNPs in combination with an external magnetic field and/or magnetizable implants allow the delivery of particles to the desired target area, fix them at the local site while the medication is released, and act locally (magnetic drug targeting) [79]. Transportation of drugs to a specific site can eliminate side effects and also reduce the dosage required. The surfaces of these particles are generally modified with organic polymers and inorganic metals or oxides to make them biocompatible and suitable for further functionalization by the attachment of various bioactive molecules [80, 81]. The process of drug localization using magnetic delivery systems is based on the competition between the forces exerted on the particles by the blood compartment and the magnetic forces generated from the magnet.

3. Diagnostic applications

  1. a.

    NMR imaging. The development of the NMR imaging technique for clinical diagnosis has prompted the need for a new class of pharmaceuticals, so-called magneto-pharmaceuticals. These drugs must be administered to a patient in order to (1) enhance the image contrast between the normal and diseased tissue and/or (2) indicate the status of organ functions or blood flow.

In vitro applications

  1. 1.

    Diagnostic applications

  2. a.

    Separation and selection. At present, considerable attention is being paid to solid-phase extraction [SPE] as a way to isolate and preconcentrate desired components from a sample matrix. SPE is a routine extraction method for determining trace-level contaminants in environmental samples. Recently, nanometer-sized particles (nanoparticles, NPs) have gained rapid and substantial progress and have a significant impact on sample extraction. SPE offers an excellent alternative to the conventional sample concentration methods, such as liquid-liquid extraction [8284]. The separation and preconcentration of the substance from large volumes of solution can be highly time consuming when using standard column SPE, and it is in this field where the use of magnetic or magnetizable adsorbents called magnetic solid-phase extraction [MSPE] gains importance. In this procedure, the magnetic adsorbent is added to a solution or suspension containing the target. This is adsorbed onto the magnetic adsorbent, and then, the adsorbent with the adsorbed target is recovered from the suspension using an appropriate magnetic separator. For separation and selection, the advantage of using magnetic nanoparticles instead magnetic microparticles is that we can prepare suspensions that are stable against sedimentation in the absence of an applied magnetic field. The applicability of iron oxide magnetic nanoparticles in MSPE is clearly evidenced by the fact that it already exists in the market companies (DYNAL Biotech) that commercialize these products (Figure 3).

Figure 3

Schematic representation of the magnetically driven transport of drugs to a specific region. A catheter is inserted into an arterial feed to the tumor, and a magnetic stand is positioned over the targeted site.

  1. b.

    Magnetorelaxometry. It was introduced as a method for the evaluation of immunoassays [85]. Magnetorelaxometry measures the magnetic viscosity, i.e., the relaxation of the net magnetic moment of a system of magnetic nanoparticles after removal of a magnetic field [86]. There are two different relaxation mechanisms. First, the internal magnetization vector of a nanoparticle relaxes in the direction of the easy axis inside the core; this is called Néel relaxation [87]. Second, particles accomplish rotational diffusion in a carrier liquid, called Brownian relaxation [88]. Néel and Brownian relaxation can be distinguished by their different relaxation times [89]. Furthermore, Brownian relaxation can take place only in liquids, whereas Néel relaxation does not depend on the dispersion of the nanoparticles. The fact that magnetorelaxometry depends on the core size, the hydrodynamic size, and the anisotropy allows this technique to distinguish between the free and bound conjugates by their different magnetic behavior and therefore can be used as an analytical tool for the evaluation of immunoassays [90]. For this application, the benefits of reducing the particle size to the nanometer size are similar to those described for separation and selection applications.

  2. c.

    Magnetic resonance imaging. At the boundary between nanomaterials and medical diagnostics, superparamagnetic iron oxide NPs are proving to be a class of novel probes useful for in vitro and in vivo cellular and molecular imaging. Superparamagnetic contrast agents have an advantage of producing an enhanced proton relaxation in magnetic resonance imaging [MRI] in comparison with paramagnetic ones. Consequently, less amounts of a SPIO agent are needed to dose the human body than a paramagnetic one. To apply the magnetic fluids to a MRI contrast agent, a SPIO should be dispersed into a biocompatible and biodegradable carrier. Recently, Muller et al. [91] comprehensively reviewed the applications of super paramagnetic iron oxide NPs as a contrast agent. However, MRIs are not convenient for in situ monitoring. Thus, a sensitive and simple technique for in situ monitoring of the NPs in living cells is desirable. Compared to conventional organic fluorescence probes, advantages of the nanometer-sized fluorescence probes mainly include their higher photostability and stronger fluorescence. The main problem in cell imaging using the fluorescent nanoprobes is that the fluorescence signal is easily affected by the background noises caused by the cells, matrix, and the nonspecific scattering lights. The high signal to noise (S/N) ratio is not easy to obtain.

  3. d.

    Bioseparation. In a biomedical study, separation of specific biological entities (e.g., DNAs, proteins, and cells) from their native environment is often required for analysis. Superparamagnetic colloids are ideal for this application because of their on-off nature of magnetization with and without an external magnetic field, enabling the transportation of biomaterials with a magnetic field. In a typical procedure for separation, the biological entities are labeled by superparamagnetic colloids and then subjected to separation by an external magnetic field [92]. Nanometer-sized magnetic particles, such as super paramagnetic iron oxide particles, have been extensively used for separation and purification of cells and biomolecules in bioprocesses [9395]. Due to their small size and high surface area, MNPs have many superior characteristics for these bioseparation applications compared to those of the conventional micrometer-sized resins or beads such as good dispersability, the fast and effective binding of biomolecules, and reversible and controllable flocculation. One of the trends in this subject area is the magnetic separation using antibodies to provide highly accurate antibodies that can specifically bind to their matching antigens on the surface of the targeted species.

  4. 2.

    Catalysis applications. In recent years, catalysts supported by MNPs have been extensively used to improve the limitation of heterogeneous catalysis. Magnetically driven, separations make the recovery of catalysts in a liquid-phase reaction much easier than using cross flow filtration and centrifugation, especially when the catalysts are in the submicrometer size range. Such small and magnetically separable catalysts could combine the advantages of high dispersion and reactivity with easy separation. In terms of recycling expensive catalysts or ligands, immobilization of these active species on MNPs leads to the easy separation of catalysts in a quasi-homogeneous system [96]. The various types of transition metal-catalyzed reactions using catalytic sites grafted onto MNPs that have emerged recently include carbon-carbon cross-coupling reactions, hydroformylation [97], hydrogenation, and polymerization [98] reactions. Other reports on MNP-supported catalysts include enzymes for carboxylate resolution, amino acids for ester hydrolysis, and organic amine catalysts promoting Knoevenagel and related reactions.

Environmental applications

A similarly important property of nanoscale iron particles is their huge flexibility for in situ applications. Modified iron nanoparticles, such as catalyzed and supported nanoparticles, have been synthesized to further enhance their speed and efficiency of remediation [99]. In spite of some still unresolved uncertainties associated with the application of iron nanoparticles, this material is being accepted as a versatile tool for the remediation of different types of contaminants in groundwater, soil, and air on both the experimental and field scales [100]. In recent years, other MNPs have been investigated for the removal of organic and inorganic pollutants.

Organic pollutants

There are a few articles about the removal of high concentrations of organic compounds which are mostly related to the removal of dyes. The MNPs have a high capacity in the removal of high concentrations of organic compounds [101103]. Dyes are present in the wastewater streams of many industrial sectors such as in dyeing, textile factories, tanneries, and in the paint industry. Therefore, the replacement of MNPs with an expensive or low efficient adsorbent for treatment of textile effluent can be a good platform which needs more detailed investigations.

Inorganic pollutants

A very important aspect in metal toxin removal is the preparation of functionalized sorbents for affinity or selective removal of hazardous metal ions from complicated matrices. MNPs are used as sorbents for the removal of metal ions. Thus, MNPs show a high [104106] capacity and efficiency in the removal of different metal ions due to their high surface area with respect to micron-sized sorbents. These findings can be used to design an appropriate adsorption treatment plan for the removal and recovery of metal ions from wastewaters.

Analytical applications

  1. 1.

    Fluorescence techniques. Due to their small size, magnetic luminescent NPs offer a larger surface area-to-volume ratio than currently used microbeads, which result in a good reaction homogeneity and faster reaction kinetics. Thus, the preparation of magnetic fluorescent particles, such as polystyrene magnetic beads with entrapped organic dyes/quantum dots [QDs] or shells of QDs [107], iron oxide particles coated with dye-doped silica shells, and silica NPs embedded with iron oxide and QDs, is easier. However, their application is limited mostly to biological applications, such as cellular imaging. Only a few papers have reported the use of dual-functional NPs for multiplexed quantitative bioanalysis. The magnetic properties of the MLNPs allowed their manipulation by an external magnetic field without the need of centrifugation or filtration. Their optical characteristics (sharp emission, photostability, long lifetime) facilitated the implementation of an internal calibration in the detection system. This introduced a unique internal quality control and easy quantifications in the multiplexed immunoanalysis. This method developed and enables a direct, simple, and quantitative multiplex protein analysis using conventional organic dyes and can be applied for disease diagnostics and detection of biological threats.

  2. 1.

    Inorganic and hybrid coatings (or shells) on colloidal templates have been prepared by precipitation and surface reactions [108]. By adequate selection of the experimental conditions, mainly the nature of the precursors, temperature, and pH, this method can give uniform, smooth coatings, and therefore lead to monodispersed spherical composites. Using this technique, submicrometer-sized anionic polystyrene lattices have been coated with uniform layers of iron compounds [109] by aging at an elevated temperature and by dispersions of the polymer colloid in the presence of aqueous solutions of ferric chloride, urea, hydrochloric acid, and polyvinyl pyrrolidone. One of the most promising techniques for the production of superparamagnetic composites is the layer-by-layer self-assembly method. This method was firstly developed for the construction of ultrathin films [110] and was further developed by Caruso et al. [111] for the controlled synthesis of novel nanocomposite core-shell materials and hollow capsules. It consists of the stepwise adsorption of charged polymers or nanocolloids and oppositely charged polyelectrolytes onto flat surfaces or colloidal templates, exploiting primarily electrostatic interactions for layer buildup. Using this strategy, colloidal particles have been coated with alternating layers of polyelectrolytes, nanoparticles, and proteins [112]. Furthermore, Caruso et al. have demonstrated that submicrometer-sized hollow silica spheres or polymer capsules can be obtained after removal of the template from the solid-core multilayered-shell particles either by calcination or by chemical extraction. Their work in the preparation of iron oxide superparamagnetic and monodisperse, dense, and hollow spherical particles that could be used for biomedical applications deserves special mention.

  3. 2.

    Encapsulation of magnetic nanoparticles in polymeric matrixes. Encapsulation of inorganic particles into organic polymers endows the particles with important properties that bare uncoated particles lack [113]. Polymer coatings on particles enhance compatibility with organic ingredients, reduce susceptibility to leaching, and protect particle surfaces from oxidation. Consequently, encapsulation improves dispersibility, chemical stability, and reduces toxicity [114]. Polymer-coated magnetite nanoparticles have been synthesized by seed precipitation polymerization of methacrylic acid and hydroxyethyl methacrylate in the presence of the magnetite nanoparticles [115]. Cross-linking of polymers has also been reported as an adequate method for the encapsulation of magnetic nanoparticles. To prepare the composites by this method, first, mechanical energy needs to be supplied to create a dispersion of magnetite in the presence of aqueous albumin [116], chitosan [117], or PVA polymers [118]. More energy creates an emulsion of the magnetic particle sol in cottonseed [119], mineral [120], or vegetable oil [121]. Depending upon composition and reaction conditions, the addition of a cross-linker and heat results in a polydispersed magnetic latex, 0.3 microns in diameter, with up to 24 wt.% in magnetite content [122]. Recently, the preparation of superparamagnetic latex via inverse emulsion polymerization has been reported [123]. A 'double-hydrophilic' diblock copolymer, present during the precipitation of magnetic iron oxide, directs nucleation, controls growth, and sterically stabilizes the resulting 5-nm superparamagnetic iron oxide. After drying, the coated particles repeptize creating a ferrofluid-like dispersion. Inverse emulsification of the ferrofluid into decane, aided by small amounts of diblock copolymer emulsifier along with ultrasonication, creates mini droplets (180 nm) filled with magnetic particles and monomer. Subsequent polymerization generates magnetic latex. A novel approach to prepare superparamagnetic polymeric nanoparticles by synthesis of the magnetite core and polymeric shell in a single inverse microemulsion was reported by Chu et al. [124]. Stable magnetic nanoparticle dispersions with narrow size distribution were thus produced. The microemulsion seed copolymerization of methacrylic acid, hydroxyethyl methacrylate, and cross-linker resulted in a stable hydrophilic polymeric shell around the nanoparticles. Changing the monomer concentration and water/surfactant ratio controls the particle size.

    Encapsulation of magnetic nanoparticles in inorganic matrixes. An appropriate tuning of the magnetic properties is essential for the potential use of the superparamagnetic composites. In this way, the use of inorganic matrixes, in particular of silica, as dispersion media of superparamagnetic nanocrystals has been reported to be an effective way to modulate the magnetic properties by a simple heating process [125]. Another advantage of having a surface enriched in silica is the presence of surface silanol groups that can easily react with alcohols and silane coupling agents [126] to produce dispersions that are not only stable in nonaqueous solvents, but also provide the ideal anchorage for covalent bonding of specific ligands. The strong binding makes desorption of these ligands a difficult task. In addition, the silica surface confers a high stability to suspensions of the particles at high volume fractions, changes in pH, or electrolyte concentration [127]. Recently, we have been successful in preparing submicronic silica-coated maghemite hollow and dense spheres with a high loading of magnetic material by aerosol pyrolysis [128]. Silica-coated γ-Fe2O3 hollow spherical particles with an average size of 150 nm were prepared by aerosol pyrolysis of methanol solutions containing iron ammonium citrate and tetraethoxysilane [TEOS] at a total salt concentration of 0.25 M [129]. During the first stage, the rapid evaporation of the methanol solvent favors the surface precipitation (i.e., formation of hollow spheres) of the components [130]. The low solubility of the iron ammonium citrate in methanol when compared with that of TEOS promotes the initial precipitation of the iron salt solid shell. During the second stage, the probable continuous shrinkage of this iron salt solid shell facilitates the enrichment at the surface of the silicon oxide precursor (TEOS). In the third stage, the thermal decomposition of precursors produces the silica-coated γ-Fe2O3 hollow spheres. The formation of the γ-Fe2O3 is associated with the presence of carbonaceous species coming from the decomposition of the methanol solvent and from the iron ammonium citrate and TEOS. On the other hand, the aerosol pyrolysis of iron nitrate and TEOS at a total salt concentration of 1 M produced silica-coated γ-Fe2O3 dense spherical particles with an average size of 250 nm. The increase in salt concentration to a value of 1 M favors the formation of dense spherical particles. Sedimentation studies of these particles have shown that they are particularly useful for separation applications [131]. A W/O microemulsion method has also been used for the preparation of silica-coated iron oxide nanoparticles [132]. Three different non-ionic surfactants (Triton X-100, Dow Chemical Company, Midland, MI, USA; Igepal CO-520, and Brij-97) have been used for the preparation of microemulsions, and their effects on the particle size, crystallinity, and the magnetic properties have been studied

  4. 3.

    The iron oxide nanoparticles are formed by the coprecipitation reaction of ferrous and ferric salts with inorganic bases. A strong base, NaOH, and a comparatively mild base, NH4OH, have been used with each surfactant to observe whether the basicity influences the crystallization process during particle formation. All these systems show magnetic behavior close to that of superparamagnetic materials. By using this method, magnetic nanoparticles as small as 1 to 2 nm and of very uniform size (standard deviation less than 10%) have been synthesized. A uniform silica coating as thin as 1 nm encapsulating the bare nanoparticles is formed by the base-catalyzed hydrolysis and the polymerization reaction of TEOS in the microemulsion. It is worth mentioning that the small particle size of the composite renders these particles a potential candidate for their use in in vivo applications.

Size selection methods

Biomedical applications like magnetic resonance imaging, magnetic cell separation, or magnetorelaxometry control the magnetic properties of the nanoparticles in magnetic fluids. Furthermore, these applications also depend on the hydrodynamic size. Therefore, in many cases, only a small portion of particles contributes to the desired effect. The relative amount of the particles with the desired properties can be increased by the fractionation of magnetic fluids [133]. Common methods currently used for the fractionation of magnetic fluids are centrifugation [134] and size-exclusion chromatography [135]. All these methods separate the particles via nonmagnetic properties like density or size. Massart et al [136] have proposed a size sorting procedure based on the thermodynamic properties of aqueous dispersions of nanoparticles. The positive charge of the maghemite surface allows its dispersion in aqueous acidic solutions and the production of dispersions stabilized through electrostatic repulsions. By increasing the acid concentration (in the range 0.1 to 0.5 mol l-1), interparticle repulsions are screened, and phase transitions are induced. Using this principle, these authors describe a two-step size sorting process in order to obtain significant amounts of nanometric monosized particles with diameters between typically 6 and 13 nm. As the surface of the latter is not modified by the size sorting process, usual procedures are used to disperse them in several aqueous or oil-based media. Preference should be given, however, to partitions based on the properties of interest, in this case, the magnetic properties. So far, magnetic methods have been used only for the separation of magnetic fluids, for example, to remove aggregates by magnetic filtration [137]. Recently, the fractionation of magnetic nanoparticles by flow field-flow fractionation was reported [138]. Field-flow fractionation is a family of analytical separation techniques [139, 140], in which the separation is carried out in a flow with a parabolic profile running through a thin channel. An external field is applied at a right angle to force the particles toward the so-called accumulation wall [141, 142].


  1. 1.

    Tartaj P, Morales MDD, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ: The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D: Appl Phys 2003, 36: R182-R197. 10.1088/0022-3727/36/13/202

  2. 2.

    Faraji M, Yamini Y, Rezaee M: Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization and applications. J Iran Chem Soc 2010, 7(1):1–37. 10.1007/BF03245856

  3. 3.

    Niemeyer CM: Angew Chem Int Ed. 2001, 40: 4128. 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S

  4. 4.

    Davaran S, Entezami AA: Synthesis and hydrolysis of modified poly vinyl alcohols containing Ibuprofen pendent groups. Iran Polym J 1996, 5(3):188–191.

  5. 5.

    Spanhel L, Haase M, Weller H, Henglein A: Surface Modification and Stability of Strong Luminescing CdS-Particles. J Am Chem Soc 1987, 109: 5649. 10.1021/ja00253a015

  6. 6.

    Steigerwald ML, Brus LE: Synthesis and Surface Reactions of Quantum Semiconductor Nanoclusters Annu. Rev Mater Sci 1989, 19: 471. 10.1146/

  7. 7.

    Steigerwald ML, Brus LE: la3 bination as opposed to improving the minority carrier. Acc Chem Res 1990, 23: 183. 10.1021/ar00174a003

  8. 8.

    Goldstein AN, Echer CM, Alivisatos AP: Melting in semiconductor nanocrystals. Science 1992, 256: 1425. 10.1126/science.256.5062.1425

  9. 9.

    Charles SW, Popplewell J: Properties and applications of magnetic liquids. In Hand Book of Magnetic Materials. Volume 2. Edited by: Buschow KHJ. Colorado. Wiley; 1986:153.

  10. 10.

    Bangs LB: New developments in particle-based immonoassays: introduction. Pure Appl Chem 1996, 68: 1873. 10.1351/pac199668101873

  11. 11.

    Rye PD: Sweet and Sticky: Carbohydrate-coated magnetic beads. Bio/Technology 1996, 14: 155. 10.1038/nbt0296-155

  12. 12.

    Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K: Block copolymer micelles for drug delivery: loading and release of doxorubicin. J Control Release 1997, 48: 195–201. 10.1016/S0168-3659(97)00039-4

  13. 13.

    Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K: Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res 1995, 12: 192–195. 10.1023/A:1016266523505

  14. 14.

    Denizot B, Tanguy G, Hindre F, Rump E, Lejeune JJ, Jallet P: The preparation of magnetite nanoparicles for biomedical. J Colloid Interface Sci 1999, 209: 66. 10.1006/jcis.1998.5850

  15. 15.

    Wormuth K: Superparamagnetic Latex via Inverse Emulsion Polymerization. J Colloid Interface Sci 2001, 241: 366. 10.1006/jcis.2001.7762

  16. 16.

    Portet D, Denizot B, Rump E, Lejeune JJ, Jallet P: Nonpolymeric coatings of iron oxide colloids for biological. J Colloid Interface Sci 2001., 238:

  17. 17.

    Philipse AP, van Bruggen MP, Pathmamanoharan C: The preparation of magnetite nanoparicles for biomedical. Langmuir 1994, 10: 92. 10.1021/la00013a014

  18. 18.

    Garcell L, Morales MP, Andres-Verges M, Tartaj P, Serna CJ: a significant enhancement in the colloidal properties, such. J Colloid Interface Sci 1998, 205: 470. 10.1006/jcis.1998.5654

  19. 19.

    Cabuil V: Dekker Encyclopedia of Nanoscience and Nanotechnology, Chapter 119 Magnetic Nanoparticles:Preparation and Properties. Roldan group puplications 2004.

  20. 20.

    Morcos SK: Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 2007, 80(950):73–76. 10.1259/bjr/17111243

  21. 21.

    Ersoy H, Rybicki FJ: Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007, 26(5):1190–1197. 10.1002/jmri.21135

  22. 22.

    Thakral C, Alhariri J, Abraham JL: Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadoliniumenhanced MRI scans: case report and implications. Constrast Media Mol Imaging 2007, 2(4):199–205. 10.1002/cmmi.146

  23. 23.

    Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA: Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 2005, 57(4):785–796. discussion 785–96 discussion 785-96

  24. 24.

    Moghimi SM, Hunter AC, Murray JC: Long circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53(2):283–318.

  25. 25.

    Sosnovik DE, Nahrendorf M, Weissleder R: Molecular magnetic resonance imaging in cardiovascular medicine. Circulation 2007, 115(15):2076–2086. 10.1161/CIRCULATIONAHA.106.658930

  26. 26.

    Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, et al.: Renal clearance of quantum dots. Nat Biotechnol 2007, 25(10):1165–1170. 10.1038/nbt1340

  27. 27.

    Murray CB, Norris DJ, Bawendi MG: Synthesis and characterization of nearly monodisperse Cde (E = S, Se, Te) semiconductor nanocrystallites. J Am Chem Soc 1993, 115(19):8706–8715. 10.1021/ja00072a025

  28. 28.

    Peng XG, Manna L, Yang WD, Wickham J, Scher E, et al.: Shape control of CdSe nanocrystals. Nature 2000, 404(6773):59–61. 10.1038/35003535

  29. 29.

    Puntes VF, Krishnan KM, Alivisatos AP: Colloidal nanocrystal shape and size control: the case of cobalt. Science 2001, 291(5511):2115–2117. 10.1126/science.1057553

  30. 30.

    Park J, Lee E, Hwang NM, Kang MS, Kim SC, et al.: One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew Chem Int Ed 2005, 44(19):2872–2877. 10.1002/anie.200461665

  31. 31.

    Nitin N, LaConte LEW, Zurkiya O, Hu X, Bao G: Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 2004, 9(6):706–712.

  32. 32.

    Lee SJ, Jeong JR, Shin SC, Kim JC, Chang YH, et al.: Nanoparticles of magnetic ferric oxides encapsulated with poly(D,L latide-co-glycolide) and their applications to magnetic resonance imaging contrast agent. J Magn Magn Mater 2004, 272–276: 2432–2433.

  33. 33.

    Thorek DLJ, Chen A, Czupryna J, Tsourkas A: Superparamagnetic iron oxide nanoparticle probes formolecularimaging. Ann Biomed Eng 2006, 34(1):23–38. 10.1007/s10439-005-9002-7

  34. 34.

    Lopez-Quintela MA, Tojo C, Blanco MC, Rio LG, Leis JR: Microemulsion dynamics and reactions in microemulsions. Curr Opin Colloid Interface Sci 2004, 9(3–4):264–278. 10.1016/j.cocis.2004.05.029

  35. 35.

    Ayyub P, Multani M, Barma M, Palkar VR, Vijayaraghavan R: Size-induced structural phasetransitions and hyperfine properties of microcrystalline Fe2O3. J Phys C: Solid State Phys 1988, 21(11):2229–2245. 10.1088/0022-3719/21/11/014

  36. 36.

    Perez JAL, Quintela MAL, Mira J, Rivas J, Charles SW: Advances in the preparation of magnetic nanoparticles by the microemulsion method. J phys Chem B 1997, 101(41):8045–8047. 10.1021/jp972046t

  37. 37.

    Lee Y, Lee J, Bae CJ, Park JG, Noh HJ, et al.: Largescale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under reflux conditions. Adv Funct Mater 2005, 15(3):503–509. 10.1002/adfm.200400187

  38. 38.

    Sjogren CE, Johansson C, Naevestad A, Sontum PC, BrileySaebo K, et al.: Crystal size and properties of superparamagnetic iron oxide (SPIO) particles. Magn Reson Imaging 1997, 15(1):55–67. 10.1016/S0730-725X(96)00335-9

  39. 39.

    Grossman HL, Myers WR, Vreeland VJ, Bruehl R, Alper MD, et al.: Detection of bacteria in suspension by using a superconducting quantum interference device. Proc Natl Acad Sci USA 2004, 101(1):129–134. 10.1073/pnas.0307128101

  40. 40.

    Chung SH, Hoffmann A, Bader SD, Liu C, Kay B, et al.: Biological sensors based on Brownian relaxation of magnetic nanoparticles. Appl Phys Lett 2004, 85(14):2971–2973. 10.1063/1.1801687

  41. 41.

    Bao Y, Pakhomov AB, Krishnan KM: Brownian magnetic relaxation of water-based cobalt nanoparticle ferrofluids. J Appl Phys 2006, 99(8):08H107. 10.1063/1.2172203

  42. 42.

    Kim KS, Park JK: Magnetic force-based multiplexed immunoassay using superparamagnetic nanoparticles in microfluidic channel. Lab Chip 2005, 5(6):657–664. 10.1039/b502225h

  43. 43.

    Kotitz R, Weitschies W, Trahms L, Brewer W, Semmler W: Determination of the binding reaction between avidin and biotin by relaxation measurements of magnetic nanoparticles. J Magn Magn Mater 1999, 194(1–3):62–68. 10.1016/S0304-8853(98)00580-0

  44. 44.

    Grancharov SG, Zeng H, Sun SH, Wang SX, O'Brien S, et al.: Bio-functionalization of monodisperse magnetic nanoparticles and their use as biomolecular labels in a magnetic tunnel junction based sensor. J Phys Chem B 2005, 109(26):13030–13035. 10.1021/jp051098c

  45. 45.

    Jun YW, Huh YM, Choi JS, Lee JH, Song HT, et al.: Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005, 127(16):5732–5733. 10.1021/ja0422155

  46. 46.

    Yavuz CT, Mayo JT, Yu WW, Prakash A, Falkner JC, et al.: Low-field magnetic separation of monodisperse Fe3O4 nanocrystals. Science 2006, 314(5801):964–967. 10.1126/science.1131475

  47. 47.

    Griffiths CH, Ohoro MP, Smith TW: Structure, magnetic characterization, and oxidation of colloidal iron dispersions. J Appl Phys 1979, 50(11):7108–7115. 10.1063/1.325819

  48. 48.

    Peng ZA, Peng XG: Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor. J Am Chem Soc 2001, 123(1):183–184. 10.1021/ja003633m

  49. 49.

    Qu LH, Peng ZA, Peng XG: Alternative routes toward high quality CdSe nanocrystals. Nano Lett 2001, 1(6):333–337. 10.1021/nl0155532

  50. 50.

    Hines MA, Guyot-Sionnest P: Synthesis and characterization of strongly luminescing ZnS-Capped CdSe nanocrystals. JPhysChem 1996, 100(2):468–471.

  51. 51.

    Peng XG, Schlamp MC, Kadavanich AV, Alivisatos AP: Epitaxial growth of highly luminescent CdSe/CdS core/shell nanocrystals with photostability and electronic accessibility. J Am Chem Soc 1997, 119(30):7019–7029. 10.1021/ja970754m

  52. 52.

    Dabbousi BO, RodriguezViejo J, Mikulec FV, Heine JR, Mattoussi H, et al.: (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystallites. J phys Chem B 1997, 101(46):9463–9475. 10.1021/jp971091y

  53. 53.

    Rockenberger J, Scher EC, Alivisatos AP: A new nonhydrolytic single-precursor approach to surfactantcapped nanocrystals of transition metal oxides. JAm Chem Soc 1999, 121(49):11595–11596. 10.1021/ja993280v

  54. 54.

    Hyeon T, Lee SS, Park J, Chung Y, Bin Na H: Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. JAm Chem Soc 2001, 123(51):12798–12801. 10.1021/ja016812s

  55. 55.

    Park J, An KJ, Hwang YS, Park JG, Noh HJ, et al.: Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3(12):891–895. 10.1038/nmat1251

  56. 56.

    Jana NR, Chen YF, Peng XG: Size- and shapecontrolled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem Mater 2004, 16(20):3931–3935. 10.1021/cm049221k

  57. 57.

    Sun SH, Murray CB, Weller D, Folks L, Moser A: Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 2000, 287(5460):1989–1992. 10.1126/science.287.5460.1989

  58. 58.

    Chen M, Liu JP, Sun SH: One-step synthesis of FePt nanoparticles with tunable size. J Am Chem Soc 2004, 126(27):8394–8395. 10.1021/ja047648m

  59. 59.

    Sun SH, Zeng H, Robinson DB, Raoux S, Rice PM, et al.: Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004, 126(1):273–279. 10.1021/ja0380852

  60. 60.

    Weissleder R, Mahmood U: Molecular imaging. Radiology 2001, 219(2):316–333.

  61. 61.

    Rudin M, Weissleder R: Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003, 2(2):123–131. 10.1038/nrd1007

  62. 62.

    Gu HW, Zheng RK, Zhang XX, Xu B: Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J Am Chem Soc 2004, 126(18):5664–5665. 10.1021/ja0496423

  63. 63.

    Jun YW, Choi JS, Cheon J: Shape control of semiconductor and metal oxide nanocrystals through nonhydrolytic colloidal routes. Angew Chem Int Ed 2006, 45(21):3414–3439. 10.1002/anie.200503821

  64. 64.

    Nunez NO, Tartaj P, Morales P, Pozas R, Ocana M, et al.: Preparation, characterization, and magnetic properties of Fe-based alloy particles with elongated morphology. Chem Mater 2003, 15(18):3558–3563. 10.1021/cm031040f

  65. 65.

    Park SJ, Kim S, Lee S, Khim ZG, Char K, et al.: Synthesis and magnetic studies of uniform iron nanorods and nanospheres. J Am Chem Soc 2000, 122(35):8581–8582. 10.1021/ja001628c

  66. 66.

    Dumestre F, Chaudret B, Amiens C, Fromen MC, Casanove MJ, et al.: Shape control of thermodynamically stable cobalt nanorods through organometallic chemistry. Angew Chem Int Ed 2002, 41(22):4286–4289. 10.1002/1521-3773(20021115)41:22<4286::AID-ANIE4286>3.0.CO;2-M

  67. 67.

    Dumestre F, Chaudret B, Amiens C, Renaud P, Fejes P: Superlattices of iron nanocubes synthesized from Fe[N(SiMe3)(2)](2). Science 2004, 303(5659):821–823. 10.1126/science.1092641

  68. 68.

    Piao Y, Kim J, Bin Na H, Kim D, Baek JS, et al.: Wrapbake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat Mater 2008, 7(3):242–247. 10.1038/nmat2118

  69. 69.

    Liu C, Wu XW, Klemmer T, Shukla N, Weller D: Reduction of sintering during annealing of FePt nanoparticles coated with iron oxide. Chem Mater 2005, 17(3):620–625. 10.1021/cm0403457

  70. 70.

    Park JI, Cheon J: Synthesis of ''solid solution'' and ''core-shell'' type cobalt-platinum magnetic nanoparticles via transmetalation reactions. J Am Chem Soc 2001, 123(24):5743–5746. 10.1021/ja0156340

  71. 71.

    Lu AH, Salabas EL, Schuth F: Magnetic nanoparticles: Synthesis, protection, functionalization, and application. Angew Chem Int Ed 2007, 46(8):1222–1244. 10.1002/anie.200602866

  72. 72.

    Mikhaylova M, Kim DK, Bobrysheva N, Osmolowsky M, Semenov V, et al.: Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 2004, 20(6):2472–2477. 10.1021/la035648e

  73. 73.

    Kim J, Park S, Lee JE, Jin SM, Lee JH, et al.: Designed fabrication ofmultifunctionalmagnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed 2006, 45(46):7754–7758. 10.1002/anie.200602471

  74. 74.

    Wang LY, Bai JW, Li YJ, Huang Y: Multifunctional nanoparticles displaying magnetization and near-IR absorption. Angew Chem Int Ed 2008, 47(13):2439–2442. 10.1002/anie.200800014

  75. 75.

    Green M: Organometallic based strategies for metal nanocrystal synthesis. Chem Commun 2005, 24: 3002–3011.

  76. 76.

    Jeong U, Teng XW, Wang Y, Yang H, Xia YN: Superparamagnetic colloids: Controlled synthesis and niche applications. Adv Mater 2007, 19(1):33–60. 10.1002/adma.200600674

  77. 77.

    Hyeon T: Chemical synthesis of magnetic nanoparticles. Chem Commun 2003, 8: 927–934.

  78. 78.

    Casula MF, Jun YW, Zaziski DJ, Chan EM, Corrias A, et al.: The concept of delayed nucleation in nanocrystal growth demonstrated for the case of iron oxide nanodisks. J Am Chem Soc 2006, 128(5):1675–1682. 10.1021/ja056139x

  79. 79.

    Kwon SG, Piao Y, Park J, Angappane S, Jo Y, et al.: Kinetics of monodisperse iron oxide nanocrystal formation by ''heating-up'' process. JamChemSoc 2007, 129(41):12571–12584. 10.1021/ja074633q

  80. 80.

    Gupta AK, Naregalkar RR, Vaidya VD, Gupta M: Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2(1):23–39. 10.2217/17435889.2.1.23

  81. 81.

    Wu XY, Liu HJ, Liu JQ, Haley KN, Treadway JA, et al.: Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21(1):41–46. 10.1038/nbt764

  82. 82.

    Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, et al.: In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298(5599):1759–1762. 10.1126/science.1077194

  83. 83.

    Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22(8):969–976. 10.1038/nbt994

  84. 84.

    Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, et al.: Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett 2004, 4(4):703–707. 10.1021/nl035172j

  85. 85.

    Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS: The design and synthesis of polymers for eukaryotic membrane disruption. J Controlled Release 1999, 61(1–2):137–143. 10.1016/S0168-3659(99)00114-5

  86. 86.

    Sun EY, Josephson L, Weissleder R: ''Clickable''nanoparticles for targeted imaging. Mol Imaging 2006, 5(2):122–128.

  87. 87.

    White MA, Johnson JA, Koberstein JT, Turro NJ: Toward the syntheses of universal ligands for metal oxide surfaces: controlling surface functionality through click chemistry. J Am Chem Soc 2006, 128(35):11356–11357. 10.1021/ja064041s

  88. 88.

    Philipse AP, Vanbruggen MPB, Pathmamanoharan C: Magnetic silica dispersions preparation and stability of surface-modified silica particles with a magnetic core. Langmuir 1994, 10(1):92–99. 10.1021/la00013a014

  89. 89.

    Caruso F: Nanoengineering of particle surfaces. Adv Mater 2001, 13(1):11–22. 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N

  90. 90.

    Stober W, Fink A, Bohn E: Controlled growth of monodisperse silica spheres in micron size range. J Colloid Interface Sci 1968, 26(1):62–69. 10.1016/0021-9797(68)90272-5

  91. 91.

    Lu Y, Yin YD, Mayers BT, Xia YN: Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett 2002, 2(3):183–186. 10.1021/nl015681q

  92. 92.

    Vestal CR, Zhang ZJ: Synthesis and magnetic characterization of Mn and Co spinel ferrite-silica nanoparticles with tunable magnetic core. Nano Lett 2003, 3(12):1739–1743. 10.1021/nl034816k

  93. 93.

    Yi DK, Selvan ST, Lee SS, Papaefthymiou GC, Kundaliya D, et al.: Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. Jam Chem Soc 2005, 127(14):4990–4991. 10.1021/ja0428863

  94. 94.

    Yi DK, Lee SS, Papaefthymiou GC, Ying JY: Nanoparticle architectures templated by SiO2/Fe2O3 nanocomposites. Chem Mater 2006, 18(3):614–619. 10.1021/cm0512979

  95. 95.

    Kim J, Lee JE, Lee J, Yu JH, Kim BC, et al.: Magnetic fluorescent delivery vehicle using uniformmesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. Jam Chem Soc 2006, 128(3):688–689. 10.1021/ja0565875

  96. 96.

    Lee J, Lee Y, Youn JK, Bin Na H, Yu T, et al.: Simple synthesis of functionalized superparamagnetic magnetite/silica core/shell nanoparticles and their application as magnetically separable high-performance biocatalysts. Small 2008, 4(1):143–152. 10.1002/smll.200700456

  97. 97.

    Yoon TJ, Yu KN, Kim E, Kim JS, Kim BG, et al.: Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomateriats. Small 2006, 2(2):209–215. 10.1002/smll.200500360

  98. 98.

    Yoon TJ, Kim JS, Kim BG, Yu KN, Cho MH, et al.: Multifunctional nanoparticles possessing a ''magnetic motor effect'' for drug or gene delivery. Angew Chem Int Ed 2005, 44(7):1068–1071. 10.1002/anie.200461910

  99. 99.

    Wang LY, Luo J, Fan Q, Suzuki M, Suzuki IS, et al.: Monodispersed core-shell Fe3O4@Au nanoparticles. J Phys Chem B 2005, 109(46):21593–21601. 10.1021/jp0543429

  100. 100.

    Wang LY, Luo J, Maye MM, Fan Q, Qiang RD, et al.: Iron oxide-gold core-shell nanoparticles and thin film assembly. J Mater Chem 2005, 15(18):1821–1832. 10.1039/b501375e

  101. 101.

    Caruntu D, Cushing BL, Caruntu G, O'Connor CJ: Attachment of gold nanograins onto colloidal magnetite nanocrystals. Chem Mater 2005, 17(13):3398–3402. 10.1021/cm050280n

  102. 102.

    Lyon JL, Fleming DA, Stone MB, Schiffer P, Williams ME: Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett 2004, 4(4):719–723. 10.1021/nl035253f

  103. 103.

    Yasui K, Nakamura Y: Positively charged liposomes containing tumor necrosis factor in solid tumors. Biol Pharm Bull 2000, 23: 218–322.

  104. 104.

    Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C: Preparation and characterization of protein C loaded PLA nanoparticles. J Control Release 1999, 60: 179–188. 10.1016/S0168-3659(99)00073-5

  105. 105.

    Stolnik S, Illum L, Davis SS: Long circulating microparticulate drug carriers. Adv Drug Del Rev 1995, 16: 195–214. 10.1016/0169-409X(95)00025-3

  106. 106.

    van derVeen AH, Eggermont AMM, Seynhaeve AL, van Tiel TLM, Hagen T: Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats. Int J Cancer 1998, 77: 901906.

  107. 107.

    Savva M, Duda E, Huang L: A genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted poly-ethyleneglycol hains. Int J Pharm 1999, 184: 45–51. 10.1016/S0378-5173(99)00092-7

  108. 108.

    Yuyama Y, Tsujimoto M, Fujimoto Y, Oku N: Potential usage of thermosensitive liposomes for site-specific delivery of cytokines. Cancer Lett 2000, 155: 71–77. 10.1016/S0304-3835(00)00410-9

  109. 109.

    Allemann E, Gurny R, Doelker E: Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993, 39: 173–191.

  110. 110.

    Gref R, Minamitake Y, Perracchia MT, Trubetskoy V, Torchilin V, Langer R: Biodegradable long-circulating poly-meric nanospheres. Science 1994, 263: 1600–1603. 10.1126/science.8128245

  111. 111.

    Tobıo M, Gref R, Sanchez A, Langer R, Alonso MJ: Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res 1998, 15: 270–275. 10.1023/A:1011922819926

  112. 112.

    Quellec P, Gref R, Perrin L, Dellacherie E, Sommer F, Verbavatz JM, Alonso MJ: Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res 1998, 42: 45–54. 10.1002/(SICI)1097-4636(199810)42:1<45::AID-JBM7>3.0.CO;2-O

  113. 113.

    Peracchia MT, Vauthier C, Passirani C, Couvreur P, Labarre D: Complement consumption by poly(ethylene glycol)in different conformations chemically coupled to poly-(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci 1997, 61: 749–761. 10.1016/S0024-3205(97)00539-0

  114. 114.

    Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AGA, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis S, Illum L: Surface modification of poly(lac-tide-co-glycolide) nanoparticles by biodegradable poly(lac- tide)-poly(ethylene glycol) copolymer. Pharm Res 1994, 11: 1800–1808. 10.1023/A:1018931820564

  115. 115.

    Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M: Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system. J Pharm Sci 1995, 84: 493–498. 10.1002/jps.2600840420

  116. 116.

    Peracchia MT, Gref R, Minamitake Y, Domb A, Lotan N, Langer R: PEG-coated nanoparticles from amphiphilic diblock and multiblock copolymer: investigation of their encapsulation and release characteristics. J Control Release 1997, 46: 223–231. 10.1016/S0168-3659(96)01597-0

  117. 117.

    Jeong B, Bae YH, Kim SW: Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymer. J Control Release 2000, 63: 155–163. 10.1016/S0168-3659(99)00194-7

  118. 118.

    Lamprecht A, Ubrich N, Perez MH, Lehr C-M, Hoffman M, Maincent P: Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm 1999, 184: 97–105. 10.1016/S0378-5173(99)00107-6

  119. 119.

    Iwata M, McGinity JW: Preparation of multi-phase microspheres of poly(lactic acid) and poly(lactic-co-glycolic acid) containing a W/O emulsion by a multiple solvent evapora tion technique. J Microencapsulation 1992, 9: 201–214.

  120. 120.

    Blanco MD, Alonso MJ: Development and characteriza tion of protein-loaded poly(lactide-co-glycolide) nanos pheres. Eur J Pharm Biopharm 1997, 43: 287–294. 10.1016/S0939-6411(97)00056-8

  121. 121.

    Lemoine D, Preat V: Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release 1998, 54: 15–27. 10.1016/S0168-3659(97)00241-1

  122. 122.

    Peterson PL: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977, 83: 346–356. 10.1016/0003-2697(77)90043-4

  123. 123.

    Hrkach JS, Peracchia MT, Domb A, Lotan N, Langer R: Nanotechnology for biomaterials engineering: structura characterization of amphiphilic polymeric nanoparticles by 1H-NMR spectroscopy. Biomaterials 1997, 18: 27–30. 10.1016/S0142-9612(96)00077-4

  124. 124.

    Sah H: Protein behavior at the water/methylene chloride interface. J Pharm Sci 1999, 88: 1320–1325. 10.1021/js9900654

  125. 125.

    Sah H: Stabilization of protein against methylene chloride water interface-induced denaturation and aggregation. J Control Release 1999, 58: 143–151. 10.1016/S0168-3659(98)00148-5

  126. 126.

    Velge-Roussel F, Breton P, Guillon X, Lescure F, Bout D, Hoebeke J: Immunochemical characterization of antibody-coated nanoparticles. Experientia 1996, 52: 803–806. 10.1007/BF01923993

  127. 127.

    Armstrong TI, Davies MC, Illum L: Human serum albumin as a probe for protein adsorption to nanoparticles. J Drug Target 1997, 4: 389–398. 10.3109/10611869709017896

  128. 128.

    Akbarzadeh Abolfazl, Zarghami Nosratollah, Mikaeili Haleh, Asgari Davoud, Goganian Amir Mohammad, Khaksar Khiabani H: Mohammad Samiei, Soodabeh Davaran. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnology, Science and Applications 2012, 5: 1–13.

  129. 129.

    Akbarzadeh Abolfazl, Mikaeili Haleh, Zarghami Nosratollah, Mohammad Rahmati, Bsrkhordari Amin, Davaran Soodabeh: Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4magnetic nanoparticles modified with biocompatible copolymers. International Journal of Nanomedicine 2012, 7: 1–16. 10.2217/nnm.11.171

  130. 130.

    Yoo HS, Park TG: In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 2000, 68: 419–431. 9 9 10.1016/S0168-3659(00)00280-7

  131. 131.

    Davaran S, Rashidi MR, Khandaghi R, Hashemi M: Development of a novel prolonged-release nicotine transdermal patch. Pharmacological Research 2005, 5: 233–237.

  132. 132.

    Mahkam M, Assadi MG, Ramesh M, Davaran S: Linear type Azo containing Polyurethanes for colon-specific drug delivery. J Bioact Compat Polym 2004, 19: 45–53. 10.1177/0883911504041602

  133. 133.

    Garjani MR, Davaran S, Rashidi MR, Malek N: Protective effects of some Azo derivatives of 5-amino salicylic acid and their PEGylated prodrugs an acetic acid induced rat colitis. Daru 2004, 12: 24–30.

  134. 134.

    Davaran S, Rashidi MR, Hashemi M: Synthesis and hydrolytic behaviour of 2-mercaptoethyl ibuprofenate-polyethylene glycol conjugate as a novel transdermal prodrug. J Pharm Pharmacol 2003, 55: 513–517.

  135. 135.

    Davaran S, Rashidi MR, Hashemi M: Synthesis and characterization of methacrylic derivatives of 5-amino salicylic acid with pH-sensitive swelling properties. AAPS Pharmsci Tech 2001, 2: 9.

  136. 136.

    Davaran S, Rashidi MR, Ershadpour B: Preparation of acrylic-type hydrogels containing 5-amino salicylic acid. J Pharm Sci 2001, 4: 55–63.

  137. 137.

    Davaran S, Hanaee J, Khosrawi A: Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J Control Release 1998, (58):279–287.

  138. 138.

    Davaran S, Entezami AA: Hydrophilic copolymers prepared from acrylic type derivatives of ibuprofen containing hydrolyzable thioester bond. Eur Polym J 1998, (34):187–192.

  139. 139.

    Davaran S, Entezami AA: Synthesis and hydrolysis of polyurethanes cotaining ibuprofen groups. J Bioactive Compatible Polym 1997, 12: 47–58.

  140. 140.

    Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, et al.: Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol 2007, 2(8):495–499. 10.1038/nnano.2007.217

  141. 141.

    Nasir Tabrizi MH, Davaran S, Entezami AA: Synthesis of diclofenac polymeric prodrugs and their hydrolysis reactivity. Iran Polym J 1996, 5: 243–249.

  142. 142.

    Park TG: Degradation of poly (DL-lactic) microsphere: effect of molecular weight. J Control Release 1994, 30: 161–173. 10.1016/0168-3659(94)90263-1

  143. 143.

    Oh JE, Nam YS, Lee KH, Park TG: Conjugation of drug to poly(DL-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J Control Release 1999, 57: 269–280. 10.1016/S0168-3659(98)00123-0

Download references


The authors are grateful for the financial support from the Iran National Science Foundation, Drug Applied Research Center, Tabriz University of Medical Sciences and the Department of Medicinal Chemistry, Tabriz University of Medical Sciences.

Author information

Correspondence to Soodabeh Davaran.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SD conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript. AA participated in the sequence alignment and drafted the manuscript.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Akbarzadeh, A., Samiei, M. & Davaran, S. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7, 144 (2012).

Download citation


  • magnetic nanoparticles
  • synthetic routes
  • biomedical applications
  • functionalization techniques
  • characterization